# Galaxy Digital Inc.: financial statements, quarterly

GLXY · Nasdaq · CIK 1859392 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/glxy.md) · [Financials](/companies/glxy/financials.md) · [Filings](/companies/glxy/filings.md) · [Insiders](/companies/glxy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/glxy/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [0.0](/filings/0001859392-25-000005.md) | [8.9](/filings/0001859392-25-000030.md) | [8.5](/filings/0001859392-25-000082.md) | [15.8 d](/filings/0001859392-26-000016.md) | [12.9](/filings/0001859392-26-000054.md) | [8.6](/filings/0001859392-25-000030.md) | [28.4](/filings/0001859392-25-000082.md) | [10.3 d](/filings/0001859392-26-000016.md) | [10.0](/filings/0001859392-26-000054.md) | [8.6](/filings/0001859392-26-000091.md) |
| Income tax | $bn | [0.0](/filings/0001859392-25-000005.md) | [(0.0)](/filings/0001859392-25-000030.md) | [(0.0)](/filings/0001859392-25-000082.md) | [(0.0) d](/filings/0001859392-26-000016.md) | [(0.0)](/filings/0001859392-26-000054.md) | [0.0](/filings/0001859392-26-000091.md) | [0.0](/filings/0001859392-25-000082.md) | [(0.1) d](/filings/0001859392-26-000016.md) | [(0.0)](/filings/0001859392-26-000054.md) | [(0.0)](/filings/0001859392-26-000091.md) |
| Net income | $bn | [(0.0)](/filings/0001859392-25-000005.md) | [(0.1)](/filings/0001859392-25-000030.md) | [(0.0)](/filings/0001859392-25-000082.md) | [0.1 d](/filings/0001859392-26-000016.md) | [(0.3)](/filings/0001859392-26-000054.md) | [0.0](/filings/0001859392-26-000091.md) | [0.5](/filings/0001859392-25-000082.md) | [(0.5) d](/filings/0001859392-26-000016.md) | [(0.2)](/filings/0001859392-26-000054.md) | [(0.1)](/filings/0001859392-26-000091.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | [0.5](/filings/0001859392-26-000016.md) | [0.0](/filings/0001859392-25-000005.md) | [0.7](/filings/0001859392-25-000030.md) | [1.1](/filings/0001859392-25-000082.md) | [1.2](/filings/0001859392-26-000091.md) | [0.9](/filings/0001859392-26-000054.md) | [0.9](/filings/0001859392-26-000091.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | [5.9](/filings/0001859392-26-000016.md) | [0.0](/filings/0001859392-25-000005.md) | [7.4](/filings/0001859392-25-000030.md) | [9.1](/filings/0001859392-25-000082.md) | [8.5](/filings/0001859392-26-000091.md) | [6.9](/filings/0001859392-26-000054.md) | [7.2](/filings/0001859392-26-000091.md) |
| Total assets | $bn | not reported | not reported | not reported | not reported | not reported | [7.1](/filings/0001859392-26-000016.md) | [0.0](/filings/0001859392-25-000005.md) | [9.1](/filings/0001859392-25-000030.md) | [11.5](/filings/0001859392-25-000082.md) | [11.3](/filings/0001859392-26-000091.md) | [10.0](/filings/0001859392-26-000054.md) | [10.8](/filings/0001859392-26-000091.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [3.9](/filings/0001859392-26-000016.md) | not reported | [5.5](/filings/0001859392-25-000030.md) | [6.7](/filings/0001859392-25-000082.md) | [5.3](/filings/0001859392-26-000091.md) | [4.1](/filings/0001859392-26-000054.md) | [4.8](/filings/0001859392-26-000091.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [4.9](/filings/0001859392-26-000016.md) | not reported | [6.5](/filings/0001859392-25-000030.md) | [8.4](/filings/0001859392-25-000082.md) | [8.3](/filings/0001859392-26-000091.md) | [7.2](/filings/0001859392-26-000054.md) | [8.1](/filings/0001859392-26-000091.md) |
| Shareholders' equity | $bn | [1.4](/filings/0001859392-26-000016.md) | [0.0](/filings/0001859392-25-000005.md) | [0.0](/filings/0001859392-25-000005.md) | [2.1](/filings/0001859392-25-000082.md) | [2.1](/filings/0001859392-25-000082.md) | [2.2](/filings/0001859392-26-000016.md) | [0.0](/filings/0001859392-25-000005.md) | [1.5](/filings/0001859392-25-000030.md) | [1.8](/filings/0001859392-25-000082.md) | [2.0](/filings/0001859392-26-000091.md) | [1.8](/filings/0001859392-26-000054.md) | [1.8](/filings/0001859392-26-000091.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.0)](/filings/0001859392-25-000005.md) | [221 d](/filings/0001859392-25-000030.md) | [(48.5) d](/filings/0001859392-25-000082.md) | [(378) d](/filings/0001859392-26-000016.md) | [159](/filings/0001859392-26-000054.md) | [170 d](/filings/0001859392-26-000091.md) | [428 d](/filings/0001859392-25-000082.md) | [(1,074) d](/filings/0001859392-26-000016.md) | [(83.3)](/filings/0001859392-26-000054.md) | [372 d](/filings/0001859392-26-000091.md) |
| Capital expenditure | $m | not reported | not reported | [3.4 d](/filings/0001859392-25-000082.md) | [25.9 d](/filings/0001859392-26-000016.md) | [91.6](/filings/0001859392-26-000054.md) | [305 d](/filings/0001859392-26-000091.md) | [238 d](/filings/0001859392-25-000082.md) | [558 d](/filings/0001859392-26-000016.md) | [338](/filings/0001859392-26-000054.md) | [399 d](/filings/0001859392-26-000091.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [338](/filings/0001859392-25-000030.md) | [341](/filings/0001859392-25-000082.md) | [128](/filings/0001859392-26-000054.md) | [372](/filings/0001859392-26-000091.md) | [221](/filings/0001859392-25-000082.md) | [390](/filings/0001859392-26-000054.md) | [193](/filings/0001859392-26-000091.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.